Heparin Reversal Protocol
Immediate Reversal Strategy
For patients requiring urgent heparin reversal (particularly with active bleeding or intracranial hemorrhage), administer IV protamine sulfate at 1 mg for every 100 units of heparin given in the previous 2-3 hours, with a maximum single dose of 50 mg, delivered slowly over 10 minutes. 1
Standard Dosing Algorithm
Time-Based Protamine Calculation
The protamine dose must be adjusted based on timing since last heparin administration, as heparin has an approximate half-life of 30 minutes: 2
- If heparin given within 30 minutes: Full calculated dose (1-1.3 mg protamine per 100 units heparin) 3, 2
- If heparin given 30-60 minutes prior: Reduce to 0.5-0.75 mg per 100 units 3
- If heparin given 60-120 minutes prior: Reduce to 0.375-0.5 mg per 100 units 3
- After 3-5 half-lives (>2-3 hours): Protamine likely not needed 1
Specific Dosing for Full-Dose Heparin Infusion
Calculate the total heparin units administered in the preceding 2-3 hours only (not the entire cumulative dose), then administer 1 mg protamine per 100 units, maximum 50 mg per single dose. 1
Administration Protocol
Critical Administration Guidelines
- Administer by slow IV injection over 10 minutes minimum to prevent severe hypotension, bradycardia, and anaphylactoid reactions 1, 3, 2
- Never exceed 50 mg in any 10-minute period 2
- Have resuscitation equipment immediately available before administration, as fatal anaphylaxis-like reactions have been reported 2
Post-Administration Monitoring
Measure aPTT or ACT 5-10 minutes after protamine administration to confirm adequate reversal: 1, 3
- If aPTT/ACT remains elevated, administer additional protamine at 0.5 mg per 100 units of unfractionated heparin 1
- Repeat monitoring after each additional dose 1, 3
Context-Specific Modifications
Prophylactic Subcutaneous Heparin
- Do NOT routinely reverse prophylactic subcutaneous heparin 1
- Consider reversal only if aPTT is significantly prolonged 1
Cardiac Surgery with Cardiopulmonary Bypass
For operations with CPB duration <90 minutes, the fixed-dose ratio method (1.0-1.3 mg per 100 units) is appropriate. 1, 3 For longer CPB durations, use ACT-guided heparin dose-response curve methods or heparin-protamine titration to minimize protamine exposure. 1
Recent evidence suggests a fixed 250 mg dose may be comparable to ratio-based dosing in cardiac surgery patients, potentially conserving protamine without compromising reversal efficacy. 4 However, this applies specifically to post-CPB scenarios with standardized heparin protocols.
Critical Safety Considerations
High-Risk Populations for Protamine Reactions
Patients at increased risk for severe hypersensitivity reactions include: 5
- Prior protamine exposure
- Fish allergies
- Vasectomized or infertile men
- Diabetics on protamine-containing insulin (NPH)
Protamine Paradox
Excess protamine has intrinsic anticoagulant properties and may paradoxically worsen bleeding at high doses. 5, 4 This reinforces the importance of time-based dose reduction and avoiding empiric "full reversal" dosing without considering heparin metabolism.
Low Molecular Weight Heparin (LMWH) Reversal
While the question focuses on unfractionated heparin, LMWH reversal differs significantly:
Enoxaparin-Specific Protocol
- If given within 8 hours: 1 mg protamine per 1 mg enoxaparin (max 50 mg) 1, 5
- If given 8-12 hours prior: 0.5 mg protamine per 1 mg enoxaparin (max 50 mg) 1, 5
- Administer over 10 minutes 1, 5
Important caveat: Protamine only partially reverses LMWH anti-Xa activity (approximately 60-75% neutralization), and clinical effectiveness is variable. 6 Anti-Xa levels are useful before protamine but unhelpful for monitoring reversal effect. 6
Common Pitfalls to Avoid
- Calculating protamine based on total cumulative heparin dose rather than only the dose given in the preceding 2-3 hours 1, 3
- Rapid IV push administration leading to cardiovascular collapse 2
- Administering >50 mg in a single dose or 10-minute period 1, 2
- Failing to reduce dose for time elapsed since heparin administration 3, 2
- Routinely reversing prophylactic doses without clinical indication 1